The Latest Cardiac and Vascular News
ANN ARBOR, Mich., July 25, 2022 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced the establishment of its Scientific Advisory Board (SAB). The inaugural members of the Esperion SAB represent a diverse group of internationally renowned experts who will bring a depth and breadth of basic, translational, and clinical research […]
CAMBRIDGE, Mass., July 25, 2022 (GLOBE NEWSWIRE) — Verve Therapeutics, Inc. (Nasdaq: VERV), a biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced the closing of its previously announced upsized underwritten public offering of 9,583,334 shares of its common stock at […]
SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leading AI-powered disease detection and intelligent care coordination platform, announced today it is partnering with Hyperfine, Inc. (Nasdaq: HYPR), creator of the first FDA-cleared point-of-care magnetic resonance imaging (MRI) device, Swoop®. Together, they will bring MRI to the patient’s bedside and deliver valuable insights to the clinician’s fingertips for timely […]
Highlights Group sales amounted to EUR 4.2 billion, with a 7% comparable sales decline mainly caused by continued supply shortages and prolonged lockdowns in China, on the back of 9% comparable sales growth in Q2 2021 Order book remains strong; comparable order intake increased 1% and includes a 5 percentage-points […]
This press release was updated on July 28, 2022 to reflect that Cleerly secured additional Series C funding, raising its round total from $192 million to $223 million. Updated July 28, 2022: New York – July 25, 2022 — Cleerly, the company creating a new standard of care for heart disease, announced […]
STOCKHOLM, July 22, 2022 /PRNewswire/ — Continued progress during Q2 2022 ” The second quarter of 2022 provided the latest data point to confirm IRRAS’ progress toward becoming a leader in neurocritical care. Q2 represented the 8th consecutive quarter of revenue growth for our company, and our revenue of MSEK 9.7 (5.1) […]
MORRISVILLE, N.C., July 21, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) today announced that, in connection with the previously announced appointment of Rajeev Saggar, M.D., Liquidia’s new Chief Medical Officer, it has agreed to grant him an employment inducement equity award. As previously disclosed in a Current Report on […]
CARLSBAD, Calif., July 21, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that David Roman has been appointed President and Chief Executive Officer, and member of the Board […]
Estimated June Revenue Increase of 75% Year Over Year Sales Funnel Increases 9% and System Trials Increases 5% Month Over Month SUWANEE, GA, July 21, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — On July 14, 2022, SANUWAVE Health, Inc. (OTC: PINK: SNWV), a leading provider of next-generation wound care products, provided an […]
CAMBRIDGE, Mass., July 21, 2022 (GLOBE NEWSWIRE) — Verve Therapeutics, Inc. (Nasdaq: VERV), a biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced the pricing of its upsized underwritten public offering of 8,333,334 shares of its common stock at a public […]
